Growth Metrics

Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026)

Pharma-Bio Serv posted quarterly Dividends payables of $1.7 million for Q1 2026, down 0.56% on a QoQ basis from $1.7 million in Q1 2021.

Pharma-Bio Serv (PBSV) has 3 years of Dividends payables data on file, last reported at $1.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Dividends payables changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Jan 2026 stood at $1.7 million (changed N/A YoY), and the FY2019 full-year result was $1.7 million, changed N/A from the prior year.
  • Dividends payables for Q1 2026 stood at $1.7 million, down from $1.7 million in the prior quarter.
  • Across five years, Dividends payables topped out at $1.7 million in Q1 2026 and bottomed at $1.7 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Pharma-Bio Serv - - 722,374.00 1.72 Mn

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 1.72 Mn
Jan 31, 2021 1.73 Mn
Oct 31, 2019 1.73 Mn